SENTRY Antimicrobial Surveillance Program
Established in 1997 by the Jones Group/JMI laboratories through funding by SmithKline Glaxo.
Monitors antimicrobial resistance patterns of predominant pathogens.
National and International networks of sentinel hospitals supply isolates from nosocomial and community acquired infections.